Deutsche Bank’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.15M | Sell |
102,369
-49,052
| -32% | -$1.99M | ﹤0.01% | 1314 |
|
|
2025
Q1 | $7.78M | Sell |
151,421
-2,020
| -1% | -$104K | ﹤0.01% | 1078 |
|
|
2024
Q4 | $8.5M | Buy |
153,441
+74,275
| +94% | +$4.11M | ﹤0.01% | 1068 |
|
|
2024
Q3 | $2.6M | Buy |
79,166
+63,176
| +395% | +$2.08M | ﹤0.01% | 1577 |
|
|
2024
Q2 | $435K | Buy |
15,990
+4,471
| +39% | +$122K | ﹤0.01% | 2366 |
|
|
2024
Q1 | $419K | Buy |
11,519
+468
| +4% | +$17K | ﹤0.01% | 2401 |
|
|
2023
Q4 | $224K | Sell |
11,051
-240
| -2% | -$4.86K | ﹤0.01% | 2764 |
|
|
2023
Q3 | $201K | Buy |
11,291
+1,985
| +21% | +$35.3K | ﹤0.01% | 2761 |
|
|
2023
Q2 | $168K | Sell |
9,306
-2,168
| -19% | -$39.2K | ﹤0.01% | 2981 |
|
|
2023
Q1 | $144K | Buy |
11,474
+3,985
| +53% | +$50.1K | ﹤0.01% | 3161 |
|
|
2022
Q4 | $110K | Buy |
7,489
+122
| +2% | +$1.79K | ﹤0.01% | 3276 |
|
|
2022
Q3 | $126K | Sell |
7,367
-1,205
| -14% | -$20.6K | ﹤0.01% | 3182 |
|
|
2022
Q2 | $125K | Buy |
8,572
+3,846
| +81% | +$56.1K | ﹤0.01% | 3385 |
|
|
2022
Q1 | $79K | Sell |
4,726
-961
| -17% | -$16.1K | ﹤0.01% | 3611 |
|
|
2021
Q4 | $128K | Buy |
5,687
+270
| +5% | +$6.08K | ﹤0.01% | 3548 |
|
|
2021
Q3 | $116K | Sell |
5,417
-157
| -3% | -$3.36K | ﹤0.01% | 3783 |
|
|
2021
Q2 | $161K | Buy |
5,574
+1,638
| +42% | +$47.3K | ﹤0.01% | 3856 |
|
|
2021
Q1 | $127K | Sell |
3,936
-378
| -9% | -$12.2K | ﹤0.01% | 3802 |
|
|
2020
Q4 | $178K | Buy |
+4,314
| New | +$178K | ﹤0.01% | 3473 |
|